论文部分内容阅读
目的 探讨尼莫地平胶囊治疗的疗效。方法 采用双盲安慰剂对照法治疗急性缺血性脑血管病(AICVD)、蛛网膜下腔出血 (SAH)、多发性梗塞性痴呆 (MID)共 10 3例患者 ,并分别观察AICVD组的有效率、显效率 ;SAH组的脑血管痉挛 (CVS)发生率、死亡率 ;MID组的记忆、计算、生活自理能力。结果 发现AICVD治疗组显效率明显优于对照组 (P <0 0 1) ,总有效率无显著性差异 (P >0 1) ;SAH治疗组的CVS发生率明显低于对照组 ;MID治疗组的记忆、计算、生活自理能力明显高于对照组。结论 尼莫地平胶囊为治疗脑血管病的良好药物
Objective To investigate the curative effect of nimodipine capsule. Methods A double-blind placebo-controlled trial of AICVD, subarachnoid hemorrhage (SAH) and multiple infarct dementia (MID) was performed in 103 patients. AICVD Efficiency, markedly effective rate; SAH group of cerebral vasospasm (CVS) incidence and mortality; MID group memory, calculation, self-care ability. The results showed that the apparent efficiency of AICVD treatment group was significantly better than the control group (P <0.01), the total effective rate was no significant difference (P> 0 1); SAH treatment group CVS incidence was significantly lower than the control group; MID treatment group The memory, calculation, self-care ability was significantly higher than the control group. Conclusion Nimodipine capsules are a good drug for the treatment of cerebrovascular disease